Todd D. Sonoga
September 03, 2016
Todd D. Sonoga @ WFN1 News Corp.
CMO & Co-Founder

Pressure BioSciences, Inc. (OTCQB:PBIO)

 

CEO Interview: Richard Schumacher of PBIO w/ TheStreet.com Analyst John Persinos 

Pressure BioSciences, Inc. (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications. http://hvst.co/2c0EkmC  (Website)

http://hvst.co/2c0F4bC  (OTC Markets Profile)

http://hvst.co/2c0Eo65  Facebook (Like Here)
http://hvst.co/2c0EYkj  Twitter (Follow Here)


/posts/pressure-biosciences-inc-otcqb-pbio-oNRTmmzR/attachment/pbio3-jpg-018333
More from Todd D. Sonoga